BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30554887)

  • 1. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
    Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
    Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.
    Tung M; Nah G; Tang J; Marcus G; Delling FN
    Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
    Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
    Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
    J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
    Andell P; Li X; Martinsson A; Andersson C; Stagmo M; Zöller B; Sundquist K; Smith JG
    Heart; 2017 Nov; 103(21):1696-1703. PubMed ID: 28432156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience.
    Nader V; Matta A; Canitrot R; Itier R; Salameh P; Lairez O; Elbaz M; Galinier M; Azar R; Roncalli J
    Med Sci Monit; 2021 Feb; 27():e928218. PubMed ID: 33558450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and distribution of isolated aortic stenosis in Indian patients - A study from a large tertiary care hospital in north India.
    Sahu AK; Sagar P; Khanna R; Kumar S; Tewari S; Kapoor A; Garg N; Goel PK
    Indian Heart J; 2020; 72(4):272-277. PubMed ID: 32861382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Valvular Heart Disease on Clinical Outcomes in Sarcoidosis.
    Hussain B; Markson F; Mamas MA; Alraies C; Aggarwal V; Kumar G; Desai R; Paul TK
    Curr Probl Cardiol; 2023 Oct; 48(10):101866. PubMed ID: 37301487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.
    Tan MC; Yeo YH; San BJ; Suleiman A; Lee JZ; Chatterjee A; Sell-Dottin KA; Sweeney JP; Fortuin FD; Lee KS
    J Am Heart Assoc; 2024 Apr; 13(8):e030895. PubMed ID: 38587138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular Heart Disease in Adults: Management of Native Valve Disease.
    Zhang X; Hollenberg SM
    FP Essent; 2017 Jun; 457():17-22. PubMed ID: 28671805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.